• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Dpc4在几乎所有原发性和转移性胰腺内分泌癌中均有表达。

Dpc4 is expressed in virtually all primary and metastatic pancreatic endocrine carcinomas.

作者信息

Scarpa Aldo, Orlandini Simonetta, Moore Patrick S, Lemoine Nicholas R, Beghelli Stefania, Baron Antonella, Falconi Massimo, Zamboni Giuseppe

机构信息

Dipartimento di Patologia, Sezione di Anatomia Patologica, Università di Verona, Strada Le Grazie, 37134 Verona, Italy, Italy.

ICRF Molecular Oncology Unit, Department of Cancer Medicine, Imperial College School of Medicine, London, UK, UK.

出版信息

Virchows Arch. 2002 Feb;440(2):155-159. doi: 10.1007/s00428-001-0569-6.

DOI:10.1007/s00428-001-0569-6
PMID:11964045
Abstract

DPC4/Smad4 is inactivated in about 50% of pancreatic ductal cancers. It has been recently reported that this gene is also inactivated in neoplasms arising from pancreatic islet cells, a phenomenon suggested to be related to similar progressions of malignancy found in common ductal cancers. To evaluate this possibility, we analysed 20 metastases of pancreatic endocrine carcinomas and their corresponding primary lesion for inactivation of DPC4 using immunohistochemical staining. In fact, immunohistochemical labelling has been shown to correlate with DPC4 gene status with high sensitivity and specificity. The cancers included 18 nonfunctioning tumours, one gastrinoma and one ViPoma all with liver, nodal and/or adrenal metastases. Seventeen were well-differentiated and three poorly differentiated endocrine carcinomas. Dpc4 expression was absent in only one primary well-differentiated endocrine cancer and its liver metastasis, while all the remaining 19 primary tumours and their metastases stained positive for the protein. All positively staining cases showed diffuse cytoplasmic and nuclear staining in virtually all neoplastic cells. Our data suggest that DPC4 is only rarely involved in pancreatic endocrine tumourigenesis and give further weight to the hypothesis that tumours arising from pancreatic exocrine and endocrine epithelia are genetically distinct.

摘要

在大约50%的胰腺导管癌中,DPC4/Smad4基因发生失活。最近有报道称,该基因在胰岛细胞来源的肿瘤中也会失活,这一现象被认为与常见导管癌中发现的类似恶性进展有关。为评估这种可能性,我们采用免疫组化染色分析了20例胰腺内分泌癌转移灶及其相应原发灶中DPC4基因的失活情况。事实上,免疫组化标记已被证明与DPC4基因状态具有高度敏感性和特异性的相关性。这些癌症包括18例无功能性肿瘤、1例胃泌素瘤和1例血管活性肠肽瘤,均伴有肝、淋巴结和/或肾上腺转移。其中17例为高分化内分泌癌,3例为低分化内分泌癌。仅1例高分化内分泌癌原发灶及其肝转移灶中未检测到Dpc4表达,其余19例原发肿瘤及其转移灶的蛋白染色均为阳性。所有阳性染色病例在几乎所有肿瘤细胞中均显示弥漫性胞质和核染色。我们的数据表明,DPC4仅很少参与胰腺内分泌肿瘤的发生,并进一步支持了胰腺外分泌和内分泌上皮来源的肿瘤在基因上存在差异这一假说。

相似文献

1
Dpc4 is expressed in virtually all primary and metastatic pancreatic endocrine carcinomas.Dpc4在几乎所有原发性和转移性胰腺内分泌癌中均有表达。
Virchows Arch. 2002 Feb;440(2):155-159. doi: 10.1007/s00428-001-0569-6.
2
Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.胰腺肿瘤:导管癌中涉及的分子途径参与壶腹癌的发生,但不参与外分泌非导管性或内分泌肿瘤的发生。
Br J Cancer. 2001 Jan;84(2):253-62. doi: 10.1054/bjoc.2000.1567.
3
Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation.胰腺癌中dpc4的免疫组织化学标记反映基因状态:一种DPC4失活的新标记物。
Am J Pathol. 2000 Jan;156(1):37-43. doi: 10.1016/S0002-9440(10)64703-7.
4
Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas.Dpc-4蛋白几乎在所有胰腺导管内乳头状黏液性肿瘤中均有表达:与传统导管腺癌的比较。
Am J Pathol. 2000 Sep;157(3):755-61. doi: 10.1016/S0002-9440(10)64589-0.
5
DPC4/Smad4: no mutations, rare allelic imbalances, and retained protein expression in pancreatic endocrine tumors.DPC4/Smad4:胰腺内分泌肿瘤中无突变、罕见等位基因失衡且蛋白表达保留
Diagn Mol Pathol. 2003 Dec;12(4):181-6. doi: 10.1097/00019606-200312000-00001.
6
PAX8 Expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors.PAX8 在分化良好的胰腺内分泌肿瘤中的表达:与临床病理特征的相关性,并与胃肠道和肺类癌肿瘤进行比较。
Am J Surg Pathol. 2010 May;34(5):723-9. doi: 10.1097/PAS.0b013e3181da0a20.
7
Dpc4 protein in mucinous cystic neoplasms of the pancreas: frequent loss of expression in invasive carcinomas suggests a role in genetic progression.胰腺黏液性囊性肿瘤中的Dpc4蛋白:浸润性癌中表达频繁缺失提示其在基因进展中的作用。
Am J Surg Pathol. 2000 Nov;24(11):1544-8. doi: 10.1097/00000478-200011000-00011.
8
Biologically different subgroups of invasive ductal carcinoma of the pancreas: Dpc4 status according to the ratio of intraductal carcinoma components.胰腺浸润性导管癌的生物学不同亚组:根据导管内癌成分比例的Dpc4状态
Clin Cancer Res. 2004 Jun 1;10(11):3772-9. doi: 10.1158/1078-0432.CCR-03-0120.
9
DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma.DPC4/Smad4在胰腺导管腺癌中的表达与预后
J Clin Oncol. 2002 Dec 1;20(23):4531-42. doi: 10.1200/JCO.2002.12.063.
10
Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells.Smad4/DPC4对人胰腺癌细胞肿瘤发生的抑制作用及p15(ink4b)的诱导
Clin Cancer Res. 2002 Nov;8(11):3628-38.

引用本文的文献

1
Inhibition of SCAMP1 suppresses cell migration and invasion in human pancreatic and gallbladder cancer cells.抑制SCAMP1可抑制人胰腺癌细胞和胆囊癌细胞的迁移和侵袭。
Tumour Biol. 2013 Oct;34(5):2731-9. doi: 10.1007/s13277-013-0825-9. Epub 2013 May 8.
2
Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway.胰腺内分泌肿瘤:表达谱证据表明 AKT-mTOR 通路的作用。
J Clin Oncol. 2010 Jan 10;28(2):245-55. doi: 10.1200/JCO.2008.21.5988. Epub 2009 Nov 16.
3
II. The Endocrine and Pancreatic Unit at the University of Verona, Italy.
二、意大利维罗纳大学的内分泌与胰腺研究室。
HPB (Oxford). 2002;4(4):171-3. doi: 10.1080/13651820260503828.
4
Genetic abnormalities in pancreatic cancer.胰腺癌中的基因异常。
Mol Cancer. 2003 Jan 7;2:7. doi: 10.1186/1476-4598-2-7.